Pactiv Evergreen Inc. Common stock
PTVE
PTVE was delisted on the 31st of March, 2025.
148 hedge funds and large institutions have $559M invested in Pactiv Evergreen Inc. Common stock in 2024 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 52 increasing their positions, 44 reducing their positions, and 14 closing their positions.
1,467% more call options, than puts
Call options by funds: $2.63M | Put options by funds: $168K
150% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 14
18% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 44
17% more funds holding
Funds holding: 127 → 148 (+21)
6% less capital invested
Capital invested by funds: $596M → $559M (-$37.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$10.8M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$8.76M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$7.35M |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$7.11M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$98.1M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$9.96M |
| 3 |
ER
EVR Research
Richmond,
Virginia
|
-$8.79M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$8.73M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$3.02M |
PTVE Hedge Fund Activity: Q1 2024 in Review
148 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Pactiv Evergreen Inc. Common stock (PTVE) for Q1 2024, worth a combined $559M — down 6.2% from $596M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new PTVE positions and 14 closed out — a net gain of 21 holders — while 52 added to existing stakes and 44 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $10.8M. The largest seller was Morgan Stanley, cutting an estimated $98.1M.
- 148 institutional investors held Pactiv Evergreen Inc. Common stock (PTVE) as of Q1 2024, up from 127 in Q4 2023.
- Funds reported $559M of Pactiv Evergreen Inc. Common stock stock for Q1 2024, down 6.2% quarter-over-quarter.
- 35 funds opened new Pactiv Evergreen Inc. Common stock positions in Q1 2024 and 14 closed out, a net change of +21 holders.
- The largest Pactiv Evergreen Inc. Common stock buyer in Q1 2024 was Arrowstreet Capital, an estimated $10.8M added.
- The largest Pactiv Evergreen Inc. Common stock seller in Q1 2024 was Morgan Stanley, an estimated $98.1M sold.
Based on aggregated 13F filings for Q1 2024.